In agreement with the pioneer study of Beato’s group [13], these results indicate that, in the absence of hormonal stimulation, PRMT1 takes part in the silencing of a subset of progestin-responsive genes encoding key cellular functions in breast cancer cells. The gene discussed is PRMT1; the disease is breast carcinoma.